Kite Pharma, Inc. Finite-Lived Intangible Assets, Gross
Kite Pharma, Inc. had Finite-Lived Intangible Assets, Gross of $14.16 million as of 2016-12-31, per its 10-K filed 2017-02-28.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsGross · last filed 2017-02-28
- 2016-12-31: Finite-Lived Intangible Assets, Gross $14.16M.
- 2015-12-31: Finite-Lived Intangible Assets, Gross $14.69M.
| Period end | Finite-Lived Intangible Assets, Gross |
|---|---|
| 2016-12-31 | $14.16M 10-K · filed 2017-02-28 |
| 2015-12-31 | $14.69M 10-K · filed 2016-02-29 |